APOTEX INC — Rivaroxaban Importer Profile
Pharmaceutical Importer · #4 buyer for Rivaroxaban · $1.4M import value · 54 shipments · CANADA · DGFT Verified
APOTEX INC is the #4 importer of Rivaroxaban from India with $1.4M in import value and 54 verified shipments. APOTEX INC holds a 2.4% market share in Rivaroxaban imports based in CANADA. The company sources from 1 verified supplier across 54 formulations shipped to 1 country. Overall, APOTEX INC imports 14 pharmaceutical products worth $40.9M across 7 therapeutic categories.
APOTEX INC — Rivaroxaban Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Rivaroxaban to APOTEX INC?
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| APOTEX RESEARCH PRIVATE LIMITED | $1.4M | 54 | 100.0% |
APOTEX INC sources Rivaroxaban from 1 verified Indian supplier based on 54 customs records. The primary supplier is APOTEX RESEARCH PRIVATE LIMITED accounting for 100.0% of imports.
How Does APOTEX INC Compare to Nearest Rivaroxaban Importers?
Buyers ranked immediately above and below #4 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | MYLAN IRELAND C/O ALLOGA RDC, | NETHERLANDS | $4.2M | 83 | $50.0K |
| 2 | PHARMADOX HEALTHCARE LTD | MALTA | $3.9M | 194 | $20.3K |
| 4 | APOTEX INC ★ | CANADA | $1.3M | 27 | $46.9K |
| 5 | PHARMADOX HEALTHCARE LIMITED | MALTA | $1.1M | 50 | $21.0K |
| 7 | MYLAN IRELAND C/O ALLOGA RDC,. | NETHERLANDS | $911.1K | 46 | $19.8K |
APOTEX INC ranks #4 among 497 Rivaroxaban importers from India. Average shipment value of $46.9K compared to the market average of $33.2K. The closest competitors by value are MYLAN IRELAND C/O ALLOGA RDC, and PHARMADOX HEALTHCARE LTD.
Where Does APOTEX INC Import Rivaroxaban To?
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.4M | 54 | 100.0% |
APOTEX INC imports Rivaroxaban to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $1.4M.
What Rivaroxaban Formulations Does APOTEX INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| APO-RIVAROXABAN FCT 20MG 100 BTL 68679 /771313254212 BATCH LOT NO- TY8939 | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 100 BTL 68679 /771313254212 BATCH LOT NO-TY8938 | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 100 BTL 68679 /771313254212 BATCH LOT NO-TY8937 | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 500 BTL 69816 /771313257022 BATCH LOT NO- TY8942 | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 500 BTL 69816 /771313257022 BATCH LOT NO-TY8941 | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 500 BTL 69816 /771313257022 BATCH LOT NO-TY8940 | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 100 BTL 68679/771313254212 BATCH LOT NO-VA8361NOS | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 100 BTL (BATCHNO: TZ5524)NOS | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 500 BTL (BATCHNO: TZ5528)NOS | $50.0K | 1 |
| APO-RIVAROXABAN FCT 20MG 500 BTL (BATCHNO: TZ5527)NOS | $50.0K | 1 |
APOTEX INC imports 54 distinct Rivaroxaban formulations from India. The top formulation is APO-RIVAROXABAN FCT 20MG 100 BTL 68679 /771313254212 BATCH L with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Rivaroxaban into Canada
What APOTEX INC and other importers must comply with to import Rivaroxaban from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Rivaroxaban
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Rivaroxaban from India and How Much Does APOTEX INC Import?
India exported $16.5M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. APOTEX INC imports $1.4M of this total, accounting for 2.4% of India's Rivaroxaban exports with 54 shipments from CANADA. This is verified from 54 customs shipment records covering 54 distinct formulations.
What Is the Average Order Value for APOTEX INC's Rivaroxaban Imports?
APOTEX INC's average Rivaroxaban order value is $26.8K per consignment, based on 54 shipments totaling $1.4M. APOTEX INC is based in CANADA and ranks #4 among all Rivaroxaban importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Rivaroxaban to APOTEX INC?
APOTEX INC sources Rivaroxaban from 1 verified Indian supplier: APOTEX RESEARCH PRIVATE LIMITED ($1.4M, 100.0%). This is based on 54 customs records.
How Does APOTEX INC Compare to Other Rivaroxaban Importers?
APOTEX INC ranks #4 among 497 Rivaroxaban importers from India with a 2.4% market share. The top 3 importers are MYLAN IRELAND C/O ALLOGA RDC, ($4.2M), PHARMADOX HEALTHCARE LTD ($3.9M), APOTEX INC ($1.3M). APOTEX INC processed 54 shipments from CANADA.
What Other Cardiovascular Products Does APOTEX INC Import?
APOTEX INC also imports these cardiovascular products. Each links to the detailed product page.
About APOTEX INC
APOTEX INC imports 14 products worth $40.9M. Beyond Rivaroxaban, top products include Apixaban, Fluticasone, Atorvastatin, Amino, Acetaminophen. View the complete APOTEX INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: APOTEX INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as APOTEX INC's capped import value divided by total capped export value for Rivaroxaban across all Indian exporters.
- 5.Verified Records: This page is backed by 54 individual customs records matching APOTEX INC importing Rivaroxaban, covering 54 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Import Data for APOTEX INC
Access order-level details, pricing data, supplier connections, and competitive analysis for APOTEX INC's Rivaroxaban imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
APOTEX INC
Full Company Profile →
14 products · $40.9M total trade · 7 categories
APOTEX INC × Rivaroxaban
Verified from customs records
Company Overview
Top Products by APOTEX INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for APOTEX INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current order-level data, contact TransData Nexus.